The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Maternal Serum Prolactin and Prediction of Postpartum β-Cell Function and Risk of Prediabetes/Diabetes
Abstract
OBJECTIVE: The insulin resistance of mid- to late pregnancy poses a physiologic stress test for the pancreatic β-cells, which must respond by markedly increasing their secretion of insulin. This response is achieved through an expansion of β-cell mass induced by the hormones prolactin and human placental lactogen (HPL). Conversely, the furan fatty acid metabolite 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) has recently emerged as a negative regulator of β-cell function in pregnancy. Given their respective roles in the β-cell response to the stress test of gestation, we hypothesized that antepartum prolactin, HPL, and CMPF may relate to a woman’s underlying glucoregulatory physiology and hence to her metabolic status after pregnancy. RESEARCH DESIGN AND METHODS: Three hundred and sixty-seven women underwent measurement of fasting serum prolactin, HPL, and CMPF in the late-2nd/early-3rd trimester, followed by an oral glucose tolerance test (OGTT) at 3 months postpartum that enabled assessment of glucose tolerance, insulin sensitivity/resistance, and β-cell function (Insulin Secretion-Sensitivity Index-2 [ISSI-2]). RESULTS: The postpartum OGTT identified 301 women with normal glucose tolerance (NGT) and 66 with prediabetes or diabetes. Serum prolactin in pregnancy was higher in women with postpartum NGT compared with those with postpartum prediabetes/diabetes (mean 98.2 vs. 80.2 ng/mL, P = 0.0003), whereas HPL and CMPF did not differ between the groups. On multiple linear regression analyses, antepartum prolactin was an independent determinant of postpartum ISSI-2 (β = 0.0016, t = 2.96, P = 0.003). Furthermore, higher serum prolactin in pregnancy independently predicted a lower risk of postpartum prediabetes/diabetes (odds ratio 0.50, 95% CI 0.35–0.72, P = 0.0002). CONCLUSIONS: Serum prolactin in pregnancy predicts postpartum β-cell function and risk of prediabetes/diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Also, women who progressed to type 2 diabetes mellitus had lower prolactin during pregnancy than those who maintained normoglycemia after delivery [81].”
From Gestational Diabetes Mellitus: Diagnostic Approaches and Maternal-Offspring Complications (2022) · cites this paper as [81]
Citations
Cites
1 retracted
Terra, L. F., Garay-Malpartida, M., Wailemann, R. A. M., Sogayar, M. C., & Labriola, L. (2011) · Diabetologia · doi:10.1007/s00125-011-2102-z · Cited by 78
RetractedMatthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60731-5 · Cited by 3,253 · cited 7×
“From a clinical perspective, it is noteworthy that the inverse relationship between serum prolactin in pregnancy and postpartum prediabetes/diabetes persisted after adjustment for classical diabetes risk factors (age, ethnicity, family history, weight, and breast-feeding status) and even GDM, which is a particularly p…”
BackgroundInfluentialBuchanan, T. A., & Xiang, A. H. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524531 · Cited by 2,123
Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome
Goldenberg, R., & Punthakee, Z. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.011 · Cited by 611
Serotonin regulates pancreatic beta cell mass during pregnancy
Kim, H., Toyofuku, Y., Lynn, F. C., Chak, E., Uchida, T., Mizukami, H., Fujitani, Y., Kawamori, R., Miyatsuka, T., Kosaka, Y., et al. (2010) · Nature Medicine · doi:10.1038/nm.2173 · Cited by 586
Placental hormones and the control of maternal metabolism and fetal growth
Newbern, D., & Freemark, M. (2011) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32834c800d · Cited by 487 · cited 1×
“Of note, the peak of b-cell proliferation coincides with increased circulating levels of prolactin and HPL, supporting the importance of these hormones in this context (9).”
Background
Cited by
Gestational Diabetes Mellitus: Diagnostic Approaches and Maternal-Offspring Complications
Moon, J. H., & Jang, H. C. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0335 · Cited by 377
Gunderson, E. P., Lewis, C. E., Lin, Y., Sorel, M., Gross, M., Sidney, S., Jacobs, D. R., Shikany, J. M., & Quesenberry, C. P. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.7978 · Cited by 164
Time for a New Perspective on Prolactin in Metabolism
Macotela, Y., Triebel, J., & Clapp, C. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.01.004 · Cited by 149
Metabolic effects of prolactin
Pirchio, R., Graziadio, C., Colao, A., Pivonello, R., & Auriemma, R. S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1015520 · Cited by 139
Furan fatty acids – Beneficial or harmful to health?
Xu, L., Sinclair, A. J., Faiza, M., Li, D., Han, X., Yin, H., & Wang, Y. (2017) · Progress in Lipid Research · doi:10.1016/j.plipres.2017.10.002 · Cited by 103
Metadata
- Authors
- Retnakaran, R., Ye, C., Kramer, C. K., Connelly, P. W., Hanley, A. J., Sermer, M., & Zinman, B.
- Affiliations
- Mount Sinai Hospital (CA)
- St. Michael's Hospital (CA)
- Corresponding author
- Retnakaran, Ravi
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-04-26
- Volume
- 39
- Issue
- 7
- Pages
- 1250-1258
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2343756654
- Semantic Scholar
- 34418eea6e20ff98125f143eaa696df892ad0b68
- Cited by
- 64
- References
- 39
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 11 · 2023: 6 · 2022: 11 · 2021: 4 · 2020: 8 · 2019: 4 · 2018: 7 · 2017: 5 · 2016: 2
- FWCI
- 7.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (CIHR MOP-84206)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- prediabetes, diabetes risk, human placental lactogen, CMPF, furan fatty acids, insulin resistance in pregnancy, oral glucose tolerance test, postpartum glucose tolerance
- MeSH terms
- Adult, Blood Glucose, Female, Furans, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Placental Lactogen, Prediabetic State, Predictive Value of Tests, Pregnancy, Pregnancy Complications, Pregnancy Trimester, Third, Prolactin, Propionates, Prospective Studies, Regression Analysis, Risk Factors, Diabetes, Gestational, Glucose Intolerance, Postpartum Period, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Maternal Serum Prolactin and Prediction of Postpartum β-Cell Function and Risk of Prediabetes/Diabetes. https://app.cochat.ai/papers/10.2337/dc16-0043
- The paper
- Retnakaran, R., Ye, C., Kramer, C. K., Connelly, P. W., Hanley, A. J., Sermer, M., & Zinman, B. (2016). Maternal Serum Prolactin and Prediction of Postpartum β-Cell Function and Risk of Prediabetes/Diabetes. Diabetes Care. https://doi.org/10.2337/dc16-0043
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.